Medtech Insights

The uptake of innovative higher-priced powered thrombectomy devices, together with the increasing use of PE treatment procedures—both supported by favorable clinical data—will drive strong…

The Latin American PV device market will see increasing penetration of endovascular techniques and increasing uptake of premium-priced products, such as drug-eluting technologies and IVL, as well…

The Asia Pacific PV device market will grow modestly over the forecast period, driven by the high prevalence of PAD, expanding PAD-related comorbidities, and rising adoption of premium-priced drug-…

The European PV device market will see increasing penetration of endovascular techniques and increasing uptake of premium-priced products such as drug-eluting technologies and IVL, as well as a…

The US PV device market is currently seeing a high volume of innovation, with adoption of new, premium technologies and expanding indication approvals for existing devices supporting the market…

Through 2033, Japanese PV device market growth will be driven by increased adoption of endovascular techniques, along with rising adoption of premium-priced devices such as DCBs and DES. However,…

The Asia Pacific PV device market will grow modestly over the forecast period, driven by the high prevalence of PAD, expanding PAD-related comorbidities, and rising adoption of premium-priced drug-…

The Asia Pacific dialysis access treatment device market will grow modestly through 2033 driven by the increasing patient population in need of dialysis care, the expected launch of new devices…

The European PV device market will grow modestly over the forecast period, driven by increasing adoption of drug-eluting products as more clinical evidence for these technologies emerges, rising…

A large undiagnosed patient population, rising PVD diagnosis rates, and growth in endovascular procedure volumes will support continued growth in the Latin American PV device market; however,…

A large undiagnosed patient population, rising PVD diagnosis rates, and growth in endovascular procedure volumes will support continued growth in the Latin American PV device market; however, cost…

The Asia Pacific PV device market will grow modestly over the forecast period, driven by the high prevalence of PAD, an expanding patient population, and rising adoption of premium-priced drug…